ArticleDrug design, development and therapy2026
Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway.
Lin Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.